Marina Kem

1.5k total citations
18 papers, 418 citations indexed

About

Marina Kem is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Marina Kem has authored 18 papers receiving a total of 418 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Oncology, 6 papers in Pulmonary and Respiratory Medicine and 5 papers in Molecular Biology. Recurrent topics in Marina Kem's work include Radiomics and Machine Learning in Medical Imaging (4 papers), Cancer Immunotherapy and Biomarkers (4 papers) and Cancer Mechanisms and Therapy (3 papers). Marina Kem is often cited by papers focused on Radiomics and Machine Learning in Medical Imaging (4 papers), Cancer Immunotherapy and Biomarkers (4 papers) and Cancer Mechanisms and Therapy (3 papers). Marina Kem collaborates with scholars based in United States, Italy and Germany. Marina Kem's co-authors include Mari Mino–Kenudson, Ibiayi Dagogo‐Jack, Jochen K. Lennerz, Siraj M. Ali, Jessica Lee, Alice T. Shaw, Nicholas A. Jessop, Meghan J. Mooradian, Alexa B. Schrock and Jeffrey S. Ross and has published in prestigious journals such as Journal of Clinical Oncology, The EMBO Journal and Gastroenterology.

In The Last Decade

Marina Kem

18 papers receiving 412 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Marina Kem United States 10 217 151 118 70 64 18 418
Chuanhua Zhao China 12 278 1.3× 80 0.5× 141 1.2× 93 1.3× 60 0.9× 35 420
Eriko Aimono Japan 12 192 0.9× 84 0.6× 128 1.1× 82 1.2× 54 0.8× 40 374
Dariusz Woszczyk Poland 12 119 0.5× 109 0.7× 46 0.4× 77 1.1× 97 1.5× 27 397
Clarence Eng United States 8 130 0.6× 131 0.9× 79 0.7× 55 0.8× 28 0.4× 16 342
Jesús Rodríguez-Pascual Spain 10 404 1.9× 111 0.7× 125 1.1× 60 0.9× 51 0.8× 28 550
Xiang-yuan Wu China 11 313 1.4× 102 0.7× 90 0.8× 35 0.5× 105 1.6× 26 492
Hans‐Peter Allgaier Germany 13 204 0.9× 89 0.6× 177 1.5× 40 0.6× 75 1.2× 30 604
Takuma Oishi Japan 13 201 0.9× 49 0.3× 163 1.4× 83 1.2× 35 0.5× 47 417
Xin-Ke Zhang China 7 215 1.0× 65 0.4× 118 1.0× 24 0.3× 78 1.2× 9 359
Leo J. Ostruszka United States 7 209 1.0× 130 0.9× 191 1.6× 48 0.7× 18 0.3× 7 388

Countries citing papers authored by Marina Kem

Since Specialization
Citations

This map shows the geographic impact of Marina Kem's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marina Kem with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marina Kem more than expected).

Fields of papers citing papers by Marina Kem

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marina Kem. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marina Kem. The network helps show where Marina Kem may publish in the future.

Co-authorship network of co-authors of Marina Kem

This figure shows the co-authorship network connecting the top 25 collaborators of Marina Kem. A scholar is included among the top collaborators of Marina Kem based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marina Kem. Marina Kem is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Denize, Thomas, Catherine B. Meador, Jaimie L. Barth, et al.. (2023). Concordance of ASCL1, NEUROD1 and POU2F3 transcription factor‐based subtype assignment in paired tumour samples from small cell lung carcinoma. Histopathology. 83(6). 912–924. 6 indexed citations
2.
Villalba, Julian A., Angela Shih, Yin P. Hung, et al.. (2021). P38.02 Reproducibility and Accuracy of Intra-Operative Assessment on Tumor Spread Through Air Spaces in Stage 1 Lung Adenocarcinomas. Journal of Thoracic Oncology. 16(3). S457–S458. 1 indexed citations
3.
Kunitoki, Keiko, M. Lisa Zhang, Marina Kem, et al.. (2021). Lymphocyte-activation gene 3 in non-small-cell lung carcinomas: correlations with clinicopathologic features and prognostic significance. Modern Pathology. 35(5). 615–624. 13 indexed citations
4.
Park, Jong Ho, et al.. (2021). Nuclear IL‐33/SMAD signaling axis promotes cancer development in chronic inflammation. The EMBO Journal. 40(7). e106151–e106151. 51 indexed citations
5.
Villalba, Julian A., Angela Shih, Keiko Kunitoki, et al.. (2020). Accuracy and Reproducibility of Intraoperative Assessment on Tumor Spread Through Air Spaces in Stage 1 Lung Adenocarcinomas. Journal of Thoracic Oncology. 16(4). 619–629. 46 indexed citations
6.
Tapias, Luis F., Mari Mino–Kenudson, Edwin Choy, et al.. (2020). Programmed Death Ligand 1 and Immune Cell Infiltrates in Solitary Fibrous Tumors of the Pleura. The Annals of Thoracic Surgery. 112(6). 1862–1869. 2 indexed citations
7.
Dagogo‐Jack, Ibiayi, Alexa B. Schrock, Marina Kem, et al.. (2020). Clinicopathologic Characteristics of BRG1-Deficient NSCLC. Journal of Thoracic Oncology. 15(5). 766–776. 101 indexed citations
8.
Hung, Yin P., Athena L. Chen, Martin S. Taylor, et al.. (2020). Thoracic nuclear protein in testis (NUT) carcinoma: expanded pathological spectrum with expression of thyroid transcription factor‐1 and neuroendocrine markers. Histopathology. 78(6). 896–904. 27 indexed citations
9.
Zhang, M. Lisa, Marina Kem, Clifton Rodrigues, et al.. (2020). Microscopic size measurements in post‐neoadjuvant therapy resections of pancreatic ductal adenocarcinoma (PDAC) predict patient outcomes. Histopathology. 77(1). 144–155. 6 indexed citations
10.
Badran, Yousef R., Angela Shih, Donna Leet, et al.. (2020). Immune checkpoint inhibitor-associated celiac disease. Journal for ImmunoTherapy of Cancer. 8(1). e000958–e000958. 45 indexed citations
11.
Kem, Marina, Melinda Lerwill, Robert H. Young, et al.. (2020). SWI/SNF protein and claudin‐4 expression in anaplastic carcinomas arising in mucinous tumours of the ovary and retroperitoneum. Histopathology. 77(2). 231–239. 10 indexed citations
12.
Badran, Yousef R., Angela Shih, Donna Leet, et al.. (2020). 759 IMMUNE CHECKPOINT INHIBITOR-ASSOCIATED CELIAC DISEASE. Gastroenterology. 158(6). S–156. 15 indexed citations
13.
Yozu, Masato, Marina Kem, Odise Cenaj, et al.. (2019). Loss of expression of MLH1 in non‐dysplastic crypts is a harbinger of neoplastic progression in sessile serrated adenomas/polyps. Histopathology. 75(3). 376–384. 9 indexed citations
14.
Zhang, M. Lisa, Marina Kem, Meghan J. Mooradian, et al.. (2018). Differential expression of PD-L1 and IDO1 in association with the immune microenvironment in resected lung adenocarcinomas. Modern Pathology. 32(4). 511–523. 40 indexed citations
15.
Farago, Anna F., Kumiko Isse, Benjamin J. Drapkin, et al.. (2018). P3.12-02 Dynamics of DLL3 and ASCL1 Expression in SCLC Over Disease Course. Journal of Thoracic Oncology. 13(10). S970–S971. 3 indexed citations
16.
Dagogo‐Jack, Ibiayi, Alexa B. Schrock, Marina Kem, et al.. (2018). Clinicopathologic characteristics and molecular features of BRG1-deficient non-small cell lung cancer (NSCLC).. Journal of Clinical Oncology. 36(15_suppl). 12083–12083. 1 indexed citations
17.
Pergolini, Ilaria, Vicente Morales‐Oyarvide, Mari Mino–Kenudson, et al.. (2017). Tumor engraftment in patient-derived xenografts of pancreatic ductal adenocarcinoma is associated with adverse clinicopathological features and poor survival. PLoS ONE. 12(8). e0182855–e0182855. 41 indexed citations
18.
Zhang, M. Lisa, Marina Kem, Meghan J. Mooradian, et al.. (2017). Differential expression of immune inhibitory markers in association with HLA class I and the immune microenvironment in resected lung adenocarcinomas.. Journal of Clinical Oncology. 35(15_suppl). 8551–8551. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Chuanhua Zhao Breakdown of academic impact, for papers by Eriko Aimono Breakdown of academic impact, for papers by Dariusz Woszczyk Breakdown of academic impact, for papers by Clarence Eng Breakdown of academic impact, for papers by Jesús Rodríguez-Pascual Breakdown of academic impact, for papers by Xiang-yuan Wu Breakdown of academic impact, for papers by Hans‐Peter Allgaier Breakdown of academic impact, for papers by Takuma Oishi Breakdown of academic impact, for papers by Xin-Ke Zhang Breakdown of academic impact, for papers by Leo J. Ostruszka
Rankless by CCL
2026